SAN FRANCISCO, Oct. 30, 2024 /PRNewswire/ -- Lumos, the unified access platform company, today announced it has been named as a winner of the prestigious SINET16 Innovator Award for 2024.

Granger died in 1866 from childbirth complications and was identified using forensic genealogy. DNA testing confirmed the identification by matching the skull's DNA with a living descendant of ...

“We now know the skull found in the wall in Batavia as Esther Granger,” Kane County Coroner Rob Russell announced at a press conference on Thursday, surrounded by county officials and standing ...

That’s when he knows it’s not just a piece of wood; it’s a wand. At least that’s his take. There are many others in Salem, where October brings a boom of tourists, as well as questions ...

The skull was found to be that of Esther Granger. She was in born 1848, and died at the age of 17, shortly after giving birth to her first daughter. "There's this sense of closure," Svilar said.

Brian Hill/Daily Herald Share Authorities don’t know for sure how a young woman’s skull ended up in a wall of a Batavia house. But now they know whose it is, thanks to DNA testing and sleuthing.

The Kane County Coroner's Office said the skull has been identified as Esther Granger, a 17-year-old girl who died in Indiana, in May 1866—a year after the end of the Civil War. Authorities ...

Lumos Fiber was previously blocked by Lexington County from installing internet cables in the Murraywood neighborhood near Irmo following a water line strike that caused major damage to a ...

Double Point Ventures (DPV) has entered a definitive merger agreement to acquire all outstanding shares of Lumos Pharma for $38m. The transaction also includes a non-transferable contingent value ...

Lumos Pharma has announced alignment with the FDA on the final Phase III trial design for LUM-201, a treatment for children with growth hormone deficiency. Credit: New Africa/Shutterstock. Double ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Lumos Pharma, Inc. (NASDAQ: LUMO) to Double Point Ventures LLC for $4.25 per share in cash, plus one non ...

Lumos Pharma (LUMO) has entered into a definitive merger agreement, dated October 22, 2024 whereby Double Point Ventures will acquire 100% of Lumos Pharma’s outstanding shares of common stock ...